Nicholas Weber, DO
Family Medicine · Eureka, ILNPI 1336634237
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $914 of the $1,059 with a category attached, or 86.3%. 7 manufacturers reported payments, led by Organogenesis Inc. at 53.3% of the total. 2025 is the largest year on record at $453, 2.0 times the $225 reported in 2019.
Across 25 payments — averaging $42.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$564
- Misonix Inc$145
- Solventum Corporation$109
- Urgo Medical North America, LLC$108
- Molnlycke Health Care US, LLC$93
- Integra Lifesciences Corporation$22
- plus $18 from 1 others
Across 36 payments — averaging $69,346 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$2.4M
- H. Lundbeck A S$67K
What the payments were for
- Speaking & faculty fees$14514%
- Food & beverage$91486%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 13 | $564 |
| Misonix Inc | 1 | $145 |
| Solventum Corporation | 5 | $109 |
| Urgo Medical North America, LLC | 3 | $108 |
| Molnlycke Health Care US, LLC | 1 | $93 |
| Integra Lifesciences Corporation | 1 | $22 |
| Roche Diagnostics Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TheraSkin$145
- PURAPLY WOUND MATRIX$130
- Apligraf$129
How this compares
$1,059 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 39 | $39,226 |
| MounjaroTirzepatide | 11 | $11,423 |
| Breo ElliptaFluticasone/Vilanterol | 26 | $9,691 |
| EliquisApixaban | 14 | $9,430 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 94 | $3,317 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $2,238 |
| Pregabalin | 69 | $1,785 |
| Levetiracetam | 13 | $1,765 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 69 | $1,720 |
| Lurasidone Hcl | 11 | $1,521 |
| Metoprolol Succinate | 99 | $1,457 |
| Omeprazole | 108 | $1,247 |
| ValacyclovirValacyclovir Hcl | 20 | $1,106 |
| Gabapentin | 78 | $940 |
| Duloxetine Hcl | 25 | $906 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Eureka
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.